539 related articles for article (PubMed ID: 33152411)
1. A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19.
Du J; Chu E; Zhang D; Lu CM; Zhang A; Sha MY
J Virol Methods; 2021 Jan; 287():114009. PubMed ID: 33152411
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput microsphere-based immunoassay of anti-SARS-CoV-2 IgM testing for COVID-19 diagnostics.
Zhang D; Xu T; Chu E; Zhang A; Du J; Sha MY
PLoS One; 2021; 16(9):e0248444. PubMed ID: 34473705
[TBL] [Abstract][Full Text] [Related]
3. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
[TBL] [Abstract][Full Text] [Related]
4. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
[TBL] [Abstract][Full Text] [Related]
5. Determination of SARS-CoV-2 antibodies with assays from Diasorin, Roche and IDvet.
Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M
J Virol Methods; 2021 Jan; 287():113978. PubMed ID: 32979407
[TBL] [Abstract][Full Text] [Related]
6. Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay.
Zhou JA; Zeng HL; Deng LY; Li HJ
Curr Med Sci; 2021 Apr; 41(2):318-322. PubMed ID: 33877548
[TBL] [Abstract][Full Text] [Related]
7. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
[TBL] [Abstract][Full Text] [Related]
8. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
[TBL] [Abstract][Full Text] [Related]
9. A new testing platform using fingerstick blood for quantitative antibody response evaluation after SARS-CoV-2 vaccination.
Du J; Zhang D; Pathakamuri JA; Kuebler D; Yang Y; Loginova Y; Chu E; Madej R; Neves JV; Singer B; Radke H; Spencer N; Rizk E; Zhang A; Lu CM; Sha MY
Emerg Microbes Infect; 2022 Dec; 11(1):250-259. PubMed ID: 34951566
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
11. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection.
Chua KYL; Vogrin S; Bittar I; Horvath JH; Wimaleswaran H; Trubiano JA; Holmes NE; Lam Q
Pathology; 2020 Dec; 52(7):778-782. PubMed ID: 33039094
[TBL] [Abstract][Full Text] [Related]
13. Comparison of 2 fully automated tests detecting antibodies against nucleocapsid N and spike S1/S2 proteins in COVID-19.
Flinck H; Rauhio A; Luukinen B; Lehtimäki T; Haapala AM; Seiskari T; Aittoniemi J
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115197. PubMed ID: 32977117
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays.
Harley K; Gunsolus IL
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364
[TBL] [Abstract][Full Text] [Related]
15. An original multiplex method to assess five different SARS-CoV-2 antibodies.
Favresse J; Brauner J; Bodart N; Vigneron A; Roisin S; Melchionda S; Douxfils J; Ocmant A
Clin Chem Lab Med; 2021 Apr; 59(5):971-978. PubMed ID: 33554567
[TBL] [Abstract][Full Text] [Related]
16. Validation and performance comparison of three SARS-CoV-2 antibody assays.
Paiva KJ; Grisson RD; Chan PA; Huard RC; Caliendo AM; Lonks JR; King E; Tang EW; Pytel-Parenteau DL; Nam GH; Yakirevich E; Lu S
J Med Virol; 2021 Feb; 93(2):916-923. PubMed ID: 32710669
[TBL] [Abstract][Full Text] [Related]
17. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.
Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Tancevski I; Weiss G; Anliker M; Griesmacher A; Hoermann G
Clin Chem Lab Med; 2021 May; 59(6):1143-1154. PubMed ID: 33554557
[TBL] [Abstract][Full Text] [Related]
19. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
[TBL] [Abstract][Full Text] [Related]
20. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]